Ultra-Low Contrast Angiography in AKI

Recruiting now · Phase 3

Conditions studied: Acute Kidney Injury

In brief

The aim of this study is to evaluate the safety of ultra-low contrast coronary angiography in patients with pre-existing acute kidney injury.

Key facts

Study ID

NCT05906758

Run by

Tulane University

People needed

32

Starts

2025-09-05

Expected to finish

2027-12-01

Last updated by the study team

2026-05-18

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Hospitalized patients who have AKI at admission or who develop AKI during admission and require invasive coronary angiography will be included in the trial.

You may not qualify if…

• Stabilized renal function manifested by unchanged or downtrending serum creatinine during a 24-hour period prior to enrollment.
• Contraindication for invasive coronary angiography other than AKI.
• Percutaneous coronary intervention is indicated and cannot be postponed by 7 days.
• Need for renal replacement therapy before coronary angiography or planned renal replacement therapy after coronary angiography (if premeditated before coronary angiography).
• Administration of intravascular contrast media during 7 days prior to the coronary angiography or within 6 days after coronary angiography.
• Pregnant patients, prisoners, cognitively impaired subjects, age below 18 years, unable or unwilling to provide informed consent.

Where it is running

• Tulane University Medical Center — New Orleans, Louisiana, United States (enrolling)
• University Medical Center — New Orleans, Louisiana, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.